GTC Biotherapeutics (fka GTCB)

[pharm]

Donald, or is it Roy, I think the thread 8195, talking about partnering, according to the latest CC has to be updated. A partner for DIC treatment in the USA is forthcoming, wihin weeks. A Japanese partner for the same treatment will be wellcomed only in 2010.
Then GTC initiated discussions with potential partners for rec. plasma-proteins, presumably Factor 7, Factor 9 and antitrypsin. Signing this year?
Cox also mentioned coronary artery bypass surgery, as he did that before in an interview on 2/11/08. A potential market of $ 150-200 mm a year. He did not mention that partnering discussions are taking place already, but introduction into the market could be more quickly than the DIC treatment.